FDA News

Latest News

FDA Approves Expanded Label for Avacincaptad Pegol  | Image Credit: US Food and Drug Administration
FDA Expands Dosing Label for Avacincaptad Pegol for Geographic Atrophy

February 13th 2025

The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.

Kidney Disease stock imagery. | Credit: Adobe Stock
Travere Therapeutics Plans FSGS Submission for Sparsentan

February 11th 2025

FDA Grants Fast-Track Designation to Rezpegaldesleukin for Atopic Dermatitis
FDA Grants Fast Track Designation to Rezpegaldesleukin for Atopic Dermatitis

February 10th 2025

FDA Accepts Lerodalcibep BLA for LDL-C Reduction in High-Risk Patients | Image Credit: US Food and Drug Administration
FDA Accepts Lerodalcibep BLA for LDL-C Reduction in High-Risk Patients

February 10th 2025

Plan Announced to Submit BLA for FDA Approval of CORDStrom for RDEB
BLA Submission Planned for CORDStrom in RDEB

February 10th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.